Related references
Note: Only part of the references are listed.T-cell complexity and density are associated with sensitivity to neoadjuvant chemoradiotherapy in patients with rectal cancer
Takashi Akiyoshi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Impact of KRAS status on tumor response and survival after neoadjuvant treatment of locally advanced rectal cancer
Peige Zhou et al.
JOURNAL OF SURGICAL ONCOLOGY (2021)
Tumour budding in solid cancers
Alessandro Lugli et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
Yuxi Yi et al.
CLINICAL CANCER RESEARCH (2021)
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer et al.
LANCET ONCOLOGY (2021)
Radiotherapy and the gut microbiome: facts and fiction
Jing Liu et al.
RADIATION ONCOLOGY (2021)
Clinical predictors of pathological good response in locally advanced rectal cancer
Kongfeng Shao et al.
RADIATION ONCOLOGY (2021)
A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer
Klara Hammarstrom et al.
CANCERS (2021)
The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review
Marion Tonneau et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Emerging Trends for Radio-Immunotherapy in Rectal Cancer
Claudia Corro et al.
CANCERS (2021)
Long-term outcome of a phase III trial on neoadjuvant chemoradiation with capecitabine and irinotecan in patients with locally advanced rectal cancer: Updated results of the CinClare trial.
Ji Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
A multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR): The final reports.
Jing Jin et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
A Patient-Derived Organoid-Based Radiosensitivity Model for the Prediction of Radiation Responses in Patients with Rectal Cancer
Misun Park et al.
CANCERS (2021)
Pathological Predictors of Response to Neoadjuvant Treatment in Rectal Carcinoma
Mona Malekzadeh Moghani et al.
JOURNAL OF GASTROINTESTINAL CANCER (2021)
Total Neoadjuvant Therapy in Rectal Cancer A Systematic Review and Meta-analysis of Treatment Outcomes
Fausto Petrelli et al.
ANNALS OF SURGERY (2020)
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients
Francesco Sclafani et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Population-based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancer
F. J. van der Sluis et al.
BRITISH JOURNAL OF SURGERY (2020)
CoA Synthase (COASY) Mediates Radiation Resistance via PI3K Signaling in Rectal Cancer
Sylvain Ferrandon et al.
CANCER RESEARCH (2020)
Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer
Ye Yao et al.
CELL STEM CELL (2020)
Organoids as Oracles for Precision Medicine in Rectal Cancer
Kevin S. Kolahi et al.
CELL STEM CELL (2020)
The Impact of Chemotherapy Completion on the Efficacy of Irinotecan in the Preoperative Chemoradiotherapy of Locally Advanced Rectal Cancer: An Expanded Analysis of the CinClare Phase III Trial
Jingwen Wang et al.
CLINICAL COLORECTAL CANCER (2020)
Modeling rectal cancer to advance neoadjuvant precision therapy
Harinarayanan Janakiraman et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers
Amy M. Buckley et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Single-Cell-Derived Primary Rectal Carcinoma Cell Lines Reflect Intratumor Heterogeneity Associated with Treatment Response
Rudiger Braun et al.
CLINICAL CANCER RESEARCH (2020)
Gut Microbiome Composition Is Associated with a Pathologic Response After Preoperative Chemoradiation in Patients with Rectal Cancer
Bum-Sup Jang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Is there a benefit of oxaliplatin in neoadjuvant treatment of locally advanced rectal cancer? An updated meta-analysis.
Gaetan Des Guetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Neoadjuvant chemoradiation (CRT) for locally advanced rectal cancer (LARC) with or without oxaliplatin (OX): Individual patient data (IPD) meta-analysis of three randomized controlled trials (RCTs) with subgroup analyses of age cohorts.
Elisa Fontana et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).
David Sebag-Montefiore et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial.
Thierry Conroy et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial.
Julio Garcia-Aguilar et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial.
Geke Hospers et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy
Liang Guo et al.
FRONTIERS IN IMMUNOLOGY (2020)
Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence
Satoshi Murahashi et al.
BRITISH JOURNAL OF CANCER (2020)
MicroRNAs in Rectal Cancer: Functional Significance and Promising Therapeutic Value
Laura Imedio et al.
CANCERS (2020)
Predicting Response to Neoadjuvant Therapy in Colorectal Cancer Patients the Role of Messenger-and Micro-RNA Profiling
Alberto Izzotti et al.
CANCERS (2020)
Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial
Maxime J. M. van der Valk et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
Yiyi Zhang et al.
ONCOTARGETS AND THERAPY (2020)
Comprehensive Analysis of DNA Methylation and Prediction of Response to NeoadjuvantTherapy in Locally Advanced Rectal Cancer
Luisa Matos do Canto et al.
CANCERS (2020)
The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients-A Pilot Study
Wei Shi et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
Chiara Dalle Fratte et al.
ONCOLOGY RESEARCH (2020)
Mucinous and Non-Mucinous Rectal Adenocarcinoma - Differences in Treatment Response to Preoperative Radiotherapy
Karolina Vernmark et al.
JOURNAL OF PERSONALIZED MEDICINE (2020)
Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review
F. Roeder et al.
RADIATION ONCOLOGY (2020)
Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy
Tana Machackova et al.
CANCER GENOMICS & PROTEOMICS (2020)
Circulating tumor DNA and liquid biopsy in oncology
David W. Cescon et al.
NATURE CANCER (2020)
Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study
Jeanne Tie et al.
GUT (2019)
Checkpoints and beyond - Immunotherapy in colorectal cancer
Tobias Gutting et al.
SEMINARS IN CANCER BIOLOGY (2019)
Modulating the microbiome to improve therapeutic response in cancer
Jennifer L. McQuade et al.
LANCET ONCOLOGY (2019)
ctDNA as a potential prognostic marker for locally advanced rectal cancer patients with 'watch and wait' approach.
Lifeng Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Significance of perineural and lymphovascular invasion in locally advanced rectal cancer treated by preoperative chemoradiotherapy and radical surgery: Can perineural invasion be an indication of adjuvant chemotherapy?
Jin Ho Song et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Mutation in BRAF and SMAD4 associated with resistance to neoadjuvant chemoradiation therapy in locally advanced rectal cancer
Dan Jiang et al.
VIRCHOWS ARCHIV (2019)
RAD18 may function as a predictor of response to preoperative concurrent chemoradiotherapy in patients with locally advanced rectal cancer through caspase-9-caspase-3-dependent apoptotic pathway
Xueqi Yan et al.
CANCER MEDICINE (2019)
Long-course preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study
B. Cisel et al.
ANNALS OF ONCOLOGY (2019)
Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer
Sophia C. Kamran et al.
CLINICAL CANCER RESEARCH (2019)
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Cancer modeling meets human organoid technology
David Tuveson et al.
SCIENCE (2019)
Predictors and Risk Factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Population-Based Analysis
Yinuo Tan et al.
FRONTIERS IN ONCOLOGY (2019)
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
Yanhong Deng et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial
Yong Sang Hong et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A rectal cancer organoid platform to study individual responses to chemoradiation
Karuna Ganesh et al.
NATURE MEDICINE (2019)
Rectal cancer sub-clones respond differentially to neoadjuvant therapy
Lynn M. Frydrych et al.
NEOPLASIA (2019)
The clinical role of the TME in solid cancer
Nicolas A. Giraldo et al.
BRITISH JOURNAL OF CANCER (2019)
Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy
J. Joshua Smith et al.
JAMA ONCOLOGY (2019)
CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer
Hui Chang et al.
CANCER RESEARCH AND TREATMENT (2018)
Impact of age on the efficacy of oxaliplatin in the preoperative chemoradiotherapy and adjuvant chemotherapy of rectal cancer: a post hoc analysis of the CAO/ARO/AIO-04 phase III trial
R. -D. Hofheinz et al.
ANNALS OF ONCOLOGY (2018)
Prevalence and Prognostic Significance of Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer
Zohra Faiz et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer
Shinji Matsutani et al.
CANCER SCIENCE (2018)
Pattern of programmed cell death-ligand 1 expression and CD8-positive T-cell infiltration before and after chemoradiotherapy in rectal cancer
Atsushi Ogura et al.
EUROPEAN JOURNAL OF CANCER (2018)
Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients
Sally M. Shalaby et al.
GENE (2018)
Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study
Maxime J. M. van der Valk et al.
LANCET (2018)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
Franck Pages et al.
LANCET (2018)
miR-145 Antagonizes SNAI1-Mediated Sternness and Radiation Resistance in Colorectal Cancer
Yun Zhu et al.
MOLECULAR THERAPY (2018)
Analysis of Clinical characteristics to predict pathologic complete response for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
Haihua Peng et al.
JOURNAL OF CANCER (2018)
The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
Anais Chauvin et al.
CLINICAL PROTEOMICS (2018)
Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Andrea Cercek et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial
Michael R. Marco et al.
DISEASES OF THE COLON & RECTUM (2018)
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine plus /- oxaliplatin in locally advanced rectal cancer: Final results of PETACC-6.
Hans-Joachim Schmoll et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer
Marc Campayo et al.
PLOS ONE (2018)
Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer
Dengbo Ji et al.
STEM CELL REPORTS (2018)
Molecular profiling of locally-advanced rectal adenocarcinoma using microRNA expression (Review)
Cory Pettit et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling
Georg Emons et al.
MOLECULAR CANCER RESEARCH (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Gut microbiota modulation of chemotherapy efficacy and toxicity
James L. Alexander et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Association between the expression of microRNAs and the response of patients with locally advanced rectal cancer to preoperative chemoradiotherapy
Anne Haahr Mellergaard Eriksen et al.
ONCOLOGY LETTERS (2017)
Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy
Ombretta Repetto et al.
ONCOTARGET (2017)
High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
Yu-Feng Tian et al.
JOURNAL OF CANCER (2017)
High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers
Shih-Chun Lin et al.
JOURNAL OF CANCER (2017)
Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery
Priyanka Chablani et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling
S. Goncalves-Ribeiro et al.
ANNALS OF ONCOLOGY (2017)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Glynne-Jones et al.
ANNALS OF ONCOLOGY (2017)
A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis
Fahima Dossa et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Comprehensive molecular exploration identified promoter DNA methylation of the CRBP1 gene as a determinant of radiation sensitivity in rectal cancer
K. Yokoi et al.
BRITISH JOURNAL OF CANCER (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
Eisar Al-Sukhni et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
XPO1 Inhibition Enhances Radiation Response in Preclinical Models of Rectal Cancer
Isabel Ferreiro-Neira et al.
CLINICAL CANCER RESEARCH (2016)
Long-course oxaliplatin-based preoperative chemoradiation versus 5 x 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study
K. Bujko et al.
ANNALS OF ONCOLOGY (2016)
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant Therapy
Oliver S. Chow et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Rectal cancer: Neoadjuvant chemoradiotherapy
Claus Roedel et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2016)
Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study
Laura del Puerto-Nevado et al.
BMC CANCER (2016)
Predicting pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a systematic review
J. E. Ryan et al.
COLORECTAL DISEASE (2016)
PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis
Markus Hecht et al.
EUROPEAN JOURNAL OF CANCER (2016)
Implication of programmed cell death ligand 1 expression in tumor recurrence and prognosis in rectal cancer with neoadjuvant chemoradiotherapy
Susumu Saigusa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer
Teresa Gomez del Pulgar et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Distance to the Anal Verge Is Associated With Pathologic Complete Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
Sunil V. Patel et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis
Andrew G. Renehan et al.
LANCET ONCOLOGY (2016)
The Human Intestinal Microbiome in Health and Disease
Susan V. Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy
Arancha Cebrian et al.
PATHOLOGY RESEARCH AND PRACTICE (2016)
Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis
Roland S. Croner et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
M. J. McCoy et al.
BRITISH JOURNAL OF CANCER (2015)
The prognostic role of TCF4 expression in locally advanced rectal cancer patients treated with neoadjuvant chemoradiotherapy
Xue Dou et al.
CANCER BIOMARKERS (2015)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Association of beclin 1 expression with response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal carcinoma
Aziz Zaanan et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer
Cristina Carames et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2015)
Epigenetic Regulation of KLHL34 Predictive of Pathologic Response to Preoperative Chemoradiation Therapy in Rectal Cancer Patients
Ye J. Ha et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Normalization of CEA Levels Post-Neoadjuvant Therapy is a Strong Predictor of Pathologic Complete Response in Rectal Cancer
Ariella Kleiman et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Predictive markers of response to neoadjuvant therapy in rectal cancer
Luis Joaquin Carcia-Florez et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Carmen J. Allegra et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial
Julio Garcia-Aguilar et al.
LANCET ONCOLOGY (2015)
High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
Ane L. Appelt et al.
LANCET ONCOLOGY (2015)
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Claus Roedel et al.
LANCET ONCOLOGY (2015)
Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer
Toshihiro Nakao et al.
ONCOLOGY REPORTS (2015)
Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer
Feifei Teng et al.
TRANSLATIONAL RESEARCH (2015)
Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer
Camila Lopes-Ramos et al.
CANCER GENETICS (2015)
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Carmen J. Allegra et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Predictors of complete response and Disease recurrence Following chemoradiation for rectal cancer
Danielle S. Bitterman et al.
FRONTIERS IN ONCOLOGY (2015)
Perineural Invasion Is a Strong Prognostic Factor in Colorectal Cancer
Nikki Knijn et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Impact of Perineural and Lymphovascular Invasion on Oncological Outcomes in Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Surgery
J. A. Cienfuegos et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Emerging cytokine networks in colorectal cancer
Nathan R. West et al.
NATURE REVIEWS IMMUNOLOGY (2015)
CD8+and FOXP3+Tumor-Infiltrating T Cells Before and After Chemoradiotherapy for Rectal Cancer
Eiji Shinto et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients
Camila Miranda Lopes-Ramos et al.
BMC MEDICAL GENOMICS (2014)
Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathway
Zhiqi Yu et al.
CANCER LETTERS (2014)
Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
Maria-Gabriela Anitei et al.
CLINICAL CANCER RESEARCH (2014)
The effects of neoadjuvant chemoradiotherapy on physical fitness and morbidity in rectal cancer surgery patients
M. A. West et al.
EJSO (2014)
Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer
Mikaela L. Garland et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04
Michael J. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Prognostic significance of tumor budding in rectal cancer biopsies before neoadjuvant therapy
Ailin C. Rogers et al.
MODERN PATHOLOGY (2014)
Proteogenomic characterization of human colon and rectal cancer
Bing Zhang et al.
NATURE (2014)
The role of plasma cell- free DNA detection in predicting preoperative chemoradiotherapy response in rectal cancer patients
W. Sun et al.
ONCOLOGY REPORTS (2014)
Changes in the plasma levels of cytokines/chemokines for predicting the response to chemoradiation therapy in rectal cancer patients
Noriko Tada et al.
ONCOLOGY REPORTS (2014)
Upregulation of stromal cell-derived factor 1α expression is: associated with the resistance to neoadjuvant chemoradiotherapy of locally advanced rectal cancer: Angiogenic markers of neoadjuvant chemoradiation
Han Jo Kim et al.
ONCOLOGY REPORTS (2014)
Blood biomarkers are helpful in the prediction of response to chemoradiation in rectal cancer: A prospective, hypothesis driven study on patients with locally advanced rectal cancer
Jeroen Buijsen et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma
N. Hugen et al.
ANNALS OF ONCOLOGY (2013)
Elevated CEA Levels and Low Distance of the Tumor from the Anal Verge are Predictors of Incomplete Response to Chemoradiation in Patients with Rectal Cancer
Angelo Restivo et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Effect of Preoperative Radio(chemo)therapy on Long-term Functional Outcome in Rectal Cancer Patients: A Systematic Review and Meta-analysis
Martin Loos et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Mutations in Specific Codons of the KRAS Oncogene are Associated with Variable Resistance to Neoadjuvant Chemoradiation Therapy in Patients with Rectal Adenocarcinoma
Marjun P. Duldulao et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Quantified Pathologic Response Assessed as Residual Tumor Burden Is a Predictor of Recurrence-Free Survival in Patients With Rectal Cancer Who Undergo Resection After Neoadjuvant Chemoradiotherapy
Atin Agarwal et al.
CANCER (2013)
Clinical Prediction of Pathological Complete Response After Preoperative Chemoradiotherapy for Rectal Cancer
Jung Wook Huh et al.
DISEASES OF THE COLON & RECTUM (2013)
CEA - A Predictor for Pathologic Complete Response After Neoadjuvant Therapy for Rectal Cancer
Ulrik Wallin et al.
DISEASES OF THE COLON & RECTUM (2013)
Gene Methylation in Rectal Cancer: Predictive Marker of Response to Chemoradiotherapy?
Chiara Molinari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Comparative Analysis of Radiosensitizers for K-RAS Mutant Rectal Cancers
Laura B. Kleiman et al.
PLOS ONE (2013)
KRAS mutation does not predict the efficacy of neo-adjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis
Cillian Clancy et al.
SURGICAL ONCOLOGY-OXFORD (2013)
Lymphovascular Invasion is a Significant Prognosticator in Rectal Cancer Patients Who Receive Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision
Jong Hoon Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Intramural and extramural vascular invasion in colorectal cancer Prognostic Significance and Quality of Pathology Reporting
Johannes Betge et al.
CANCER (2012)
Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
Samuel Y. Ngan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial
Ralf-Dieter Hofheinz et al.
LANCET ONCOLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
P53 Status as a Predictive Biomarker for Patients Receiving Neoadjuvant Radiation-Based Treatment: A Meta-Analysis in Rectal Cancer
Min-Bin Chen et al.
PLOS ONE (2012)
CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer
Peter Jo et al.
SURGERY (2012)
Identification of a Biomarker Profile Associated With Resistance to Neoadjuvant Chemoradiation Therapy in Rectal Cancer
Julio Garcia-Aguilar et al.
ANNALS OF SURGERY (2011)
Patient-Reported Outcomes After Neoadjuvant Chemoradiotherapy for Rectal Cancer A Multicenter Prospective Observational Study
Salvatore Pucciarelli et al.
ANNALS OF SURGERY (2011)
Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy
Marco Agostini et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: Activation of MET as one mechanism for drug resistance
Rebekka Krumbach et al.
EUROPEAN JOURNAL OF CANCER (2011)
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Toshiro Sato et al.
GASTROENTEROLOGY (2011)
Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas
Nathalie Guedj et al.
HUMAN PATHOLOGY (2011)
High survivin expression as a predictor of poor response to preoperative chemoradiotherapy in locally advanced rectal cancer
Kyubo Kim et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
PREDICTIVE FACTORS OF TUMOR RESPONSE AFTER NEOADJUVANT CHEMORADIATION FOR LOCALLY ADVANCED RECTAL CANCER
Laurence Moureau-Zabotto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer
Monique Maas et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Willem van Gijn et al.
LANCET ONCOLOGY (2011)
The current landscape of locally advanced rectal cancer
Mebea Aklilu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer
Koji Yasuda et al.
RADIATION ONCOLOGY (2011)
PREDICTION OF RESPONSE TO PREOPERATIVE CHEMORADIOTHERAPY IN RECTAL CANCER BY MULTIPLEX KINASE ACTIVITY PROFILING
Sigurd Folkvord et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data
Monique Maas et al.
LANCET ONCOLOGY (2010)
Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time
Ivan Shabo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Toshiro Sato et al.
NATURE (2009)
Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer
Morten Braendengen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy
Diclehan Unsal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
K. Bujko et al.
BRITISH JOURNAL OF SURGERY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Molecular responses of rectal cancer to preoperative chemoradiation
Annelies Debucquoy et al.
RADIOTHERAPY AND ONCOLOGY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Cox-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy
FM Smith et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
P53 status and response to radiotherapy in rectal cancer:: a prospective multilevel analysis
E Lopez-Crapez et al.
BRITISH JOURNAL OF CANCER (2005)
Radiation-stimulated ERK1/2 and JNK1/2 signaling can promote cell cycle progression in human colon cancer cells
RW Carón et al.
CELL CYCLE (2005)
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy - Long-term results
A Habr-Gama et al.
ANNALS OF SURGERY (2004)
Opinion - CpG island methylator phenotype in cancer
JP Issa
NATURE REVIEWS CANCER (2004)
Anticancer drug response and expression of molecular marker in early-passage xenotransplanted colon carcinomas
I Fichtner et al.
EUROPEAN JOURNAL OF CANCER (2004)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Overexpression of the human inducible nitric oxide synthase gene enhances radiation-induced apoptosis in colorectal cancer cells via a caspase-dependent mechanism
P Chung et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2003)
Extracellular matrix proteins and chemoradiotherapy:: α5β1 integrin as a predictive marker in rectal cancer
DG Jayne et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2002)
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: An analysis of 488 patients
SP Hiotis et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2002)
Share Paper
